Objective-To evaluate the prevalence of "high risk" human papillomavirus type 16 (HPV 16) (16 & 18) types (62%) in bladder carcinomas has been reported'" recently from Japan. In India, the incidence of HPV, particularly the type 16 in cancer of the uterine cervix is very high (> 90%) in women.'6 However, so far no report on HPV prevalence in bladder carcinoma has been available from the Indian population. Since genital condylomata can easily extend to the urethra and urinary bladder,46 17 it is not unlikely that HPV infection will be found in these organs. The present study has been carried out to detect HPV DNA in cancer of the urinary bladder in men using both in situ hybridisation and polymerase chain reaction.
sitional cell carcinoma has been detected by in situ hybridisation"3 and polymerase chain reaction.'4 But most surprisingly, a very high prevalence of HPV (81%), particularly the high risk (16 & 18) types (62%) in bladder carcinomas has been reported'" recently from Japan. In India, the incidence of HPV, particularly the type 16 in cancer of the uterine cervix is very high (> 90%) in women. '6 However, so far no report on HPV prevalence in bladder carcinoma has been available from the Indian population. Since genital condylomata can easily extend to the urethra and urinary bladder,46 17 it is not unlikely that HPV infection will be found in these organs. The present study has been carried out to detect HPV DNA in cancer of the urinary bladder in men using both in situ hybridisation and polymerase chain reaction.
Materials and methods
The study comprised histopathologically confirmed 10 16 DNA sequences in 10 histologically confirmed transitional cell carcinoma of the urinary bladder. Out of 10 cases of transitional cell carcinoma only one was positive by ISH whereas using polymerase chain reaction, HPV 16 DNA was detected in two cases. Figure 1 (a, b) shows the HPV 16 DNA positivity by radioactive ISH in the transitional cell carcinoma of the urinary bladder. The presence of silver grains can be seen in the majority of cell nuclei (arrows). Figure 2 14 In the present study, we have also observed a very low prevalence of HPV 16 in transitional cell carcinoma of the urinary bladder by both ISH and PCR. Our observations are in good agreement with the earlier reports. But in sharp contrast to these findings including this report, recently Anwar et all5 using PCR assay reported a very high prevalence (81 %) of HPV in bladder carcinomas as well as in normal urinary bladder specimens (33%). The frequency of "high risk" HPV types-16, 18 and 33 was also found to be very high (62%), a rate much higher than that reported for cervical carcinomas (44%) in Japan. 33 It is difficult at present to ascertain such a high prevalence of HPV in urinary bladder carcinoma. This may be because of either technical problems associated with PCR detection of HPV or geographical variations in HPV prevalence. Further study from Japan and other regions would throw light on this aspect.
